BD Medical, a segment of Becton, Dickinson and Company, launched BD AutoShield™ Duo, a pen needle with patented dual front and back-end shields that provides greater convenience and safety before and after injecting. The technology conceals the needle, helping to alleviate pre-injection anxiety while helping to reduce the risk of accidental needle stick for patients who inject insulin or other diabetes drugs.
The BD AutoShield Duo pen needle is easier to use because there is no inner needle shield to manage and no recapping necessary, allowing people to dispose of the pen needle in a sharps container when it’s convenient to help avoid risk of an accidental needle stick.A front shield automatically covers the needle before and after an injection, and a second shield passively covers the back-end needle after injection. Additionally, the front shield helps conceal the needle to reduce injection-related anxiety. According to a Sept. 213 Research Partnership Safety Pen Needle KAP Report, many prescribers and pharmacists have reported that a less visible needle may reduce stress and other potential psychological barriers associated with injection for some patients.
In addition to helping reduce the risk of accidental needle sticks, BD AutoShield Duo pen needles include audible and visual cues for a more confident injection experience.The front shield clicks to indicate that the needle has fully penetrated the skin, and a red band appears when the injection is completed, while the back-end shield covers the rear needle point when the pen needle is removed from the pen.
BD AutoShield Duo pen needles support the current American Assn. of Diabetes Educators practice advisory for injection technique guidelines calling for the use of shorter needles, proper site rotation, and single use.They are compatible with all diabetes injection pens on the market.The product is available nationwide at major retailers and distributors.
